TTP plc Desktop Biology enables development and manufacture of DnaNudge technology

·        Novel multiplex technology developed to help consumers make healthier choices based on their genetic profile ·        TTP involved with all aspects of product development, from initial concept to prototype testing and manufacture ·        Culmination of technology and product development partnership spanning just over 3 years

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

TTP plc (TTP), a leading independent technology and product development company, today announced that its Desktop Biologyservice has enabled the fast-track development of a novel technology in partnership with DnaNudge Ltd, the developer of the world’s first DNA-based service to “nudge” consumers towards genetically optimal buying behaviour. The technology is designed to help consumers make healthier food and drink choices based on their unique genetic profile.

The DnaNudge experience provides the consumer with personalised product recommendations suited to their individual genetic makeup, delivered through a wearable device or a mobile app, to enable the individual to choose between options from a specific product family (e.g. biscuits) resulting in a “nudge” towards a heathier lifestyle. A key enabler of this is the NudgeBox and DnaCartridge, which extracts and amplifies DNA from a customer cheek swab, providing an individual genetic report based on assessment of single nucleotide polymorphisms (SNPs). The genetic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide